Crossmark

My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed

Crossref DOI link: https://doi.org/10.1186/s10194-018-0946-z

Published Online: 2018-11-27

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Martelletti, Paolo

Schwedt, Todd J. https://orcid.org/0000-0002-7780-7086
Lanteri-Minet, Michel

Quintana, Rebeca

Carboni, Veruska

Diener, Hans-Christoph

Ruiz de la Torre, Elena

Craven, Audrey

Rasmussen, Annette Vangaa

Evans, Simon

Laflamme, Annik K.

Fink, Rachel

Walsh, Donna

Dumas, Paula

Vo, Pamela
Funding

Funding for this research was provided by:

Novartis Pharma AG (N/A)
License Information

Text and Data Mining valid from 2018-11-27
More Information

Article History

Received: 5 October 2018

Accepted: 8 November 2018

First Online: 27 November 2018

Ethics approval and consent to participate

: Participants were recruited by means of existing online panels (GfK Health) and support organizations for people with migraine. Participants’ consent was obtained prior to participation in the survey. Survey data were handled confidentially and anonymity of respondents was maintained throughout the study. As such, and due to its research format, this study was exempted from ethics committee review.

: Not applicable.

:

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.